Progress report 2011: Global HIV/AIDS response
Epidemic update and health sector progress towards universal access
WHO, UNICEF, UNAIDS
30 November 2011 -- The Progress report 2011: Global HIV/AIDS response reviews progress made until the end of 2010 in scaling up access to health sector interventions for HIV prevention, treatment, care and support in low–and middle-income countries.
It is the fifth in a series of annual progress reports published since 2006 by WHO, UNICEF and UNAIDS, in collaboration with national and international partners, to monitor key components of the health sector response to the HIV epidemic.
The key findings of the report: update on the HIV epidemic; selected health sector interventions for HIV prevention; knowledge of HIV status, scaling up treatment and care for people living with HIV; scaling up services for key populations at higher risk of HIV infection; scaling up HIV services for women and children; towards elimination of mother to child transmission and improving maternal and child health in the context of HIV.
Download the report
- Global facts on HIV epidemic and progress in 2010
- Regional facts on HIV epidemic and progress in 2010
- Fact sheet on HIV/AIDS
- Feature: 10 facts on HIV/AIDS
Unparalleled global progress in HIV response but sustained investment vital
Graphs and tables from the report
Previous progress reports
HIV and young people who inject drugs
HIV and young transgender people
HIV and young men who have sex with men
HIV and young people who sell sex
Global forecasts of antiretroviral demand for 2014–2018, projection modelling of new antitretroviral formulations for 2015–2024 and update on hepatitis B and C
Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
Ending violence and discrimination against lesbian, gay, bisexual, transgender and intersex people
Fact sheet on lopinavir and ritonavir (Lpv/R) oral pellets
Supply planning for new dosage form of lopinavir and ritonavir oral pellets
Treatment optimization of HIV and hepatitis C: implications for future updates of WHO guidelines